Gardasil 9 to be introduced in Korea, the 9-valent era of cervical cancer vaccination
MSD Korea will introduce a 9-valent vaccine, Gardasil(tetravalent), a cervical cancer vaccine, including 5 more types of human papillomavirus(HPV). The vaccine is expected to prevent cervical cancer at over 90%.
The Ministry of Food and Drug Safety approved commercialization of MSD Korea’s Garda...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
